New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like New technology ‘lights up’ bacteria in wounds for better infection prevention August 27, 2024 Splicing twins: Unraveling the secrets of the minor spliceosome complex February 14, 2025 People with type 2 diabetes who eat low-carb may be able to discontinue medication October 22, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.